Fluorine-18 deoxyglucose Positron Emission Tomography, Magnetic Resonance Imaging and Bone Scintigraphy for the Diagnosis of Bone Metastases in Patients with Lung Cancer: Which One is the Best? – a Meta-analysis
Tóm tắt
Từ khóa
Tài liệu tham khảo
Parkin, 2002, Global cancer statistics, CA Cancer J Clin, 2005, 74
Deslauriers, 2002, Current surgical treatment of non-small cell lung cancer 2001, Eur Respir J Suppl, 35, S61, 10.1183/09031936.02.00271302
Beadsmore, 2003, Classification, staging, and prognosis of lung cancer, Eur J Radiol, 45, 8, 10.1016/S0720-048X(02)00287-5
Tsuya, 2007, Skeletal metastases in non-small cell lung cancer: a retrospective study, Lung Cancer, 57, 229, 10.1016/j.lungcan.2007.03.013
Rubens, 1998, Bone metastases – the clinical problem, Eur J Cancer, 34, 210, 10.1016/S0959-8049(97)10128-9
Hortobagyi, 1998, Long-term prevention of skeletal complications of metastatic breast cancer with pamidronate: protocol 19 Aredia Breast Cancer Study Group, J Clin Oncol, 16, 2038, 10.1200/JCO.1998.16.6.2038
Roodman, 2001, Biology of osteoclast activation in cancer, J Clin Oncol, 19, 3562, 10.1200/JCO.2001.19.15.3562
Einat, 2005, Imaging of malignant bone involvement by morphologic, scintigraphic, and hybrid modalities, J Nucl Med, 46, 1356
Van Houwelingen, 1993, A bivariate approach to meta-analysis, Stat Med, 12, 2273, 10.1002/sim.4780122405
Van Houwelingen, 2002, Advanced methods in meta-analysis: multivariate approach and meta-regression, Stat Med, 21, 589, 10.1002/sim.1040
Deville, 2000, Publications on diagnostic test evaluation in family medicine journals: an optimal search strategy, J Clin Epidemiol, 53, 65, 10.1016/S0895-4356(99)00144-4
Whiting, 2003, The development of QUADAS: a tool for the quality assessment of studies of diagnostic accuracy included in systematic reviews, BMC Med Res Methodol, 3, 25, 10.1186/1471-2288-3-25
Berlin, 1997, Does blinding of readers affect the results of meta-analyses? university of Pennsylvania Meta-analysis Blinding Study Group, Lancet, 350, 185, 10.1016/S0140-6736(05)62352-5
Zamora, 2006, Meta-DiSc: a software for meta-analysis of test accuracy data, BMC Med Res Methodol, 6, 31, 10.1186/1471-2288-6-31
Bury, 1998, Fluorine-18 deoxyglucose positron emission tomography for the detection of bone metastases in patients with non-small cell lung cancer, Eur J Nucl Med, 25, 1244, 10.1007/s002590050291
Earnest, 1999, Suspected non-small cell lung cancer: incidence of occult brain and skeletal metastases and effectiveness of imaging for detection – pilot study, Radiology, 211, 137, 10.1148/radiology.211.1.r99ap34137
Schirrmeister, 2001, Prospective evaluation of the clinical value of planar bone Scans, SPECT, and 18F-labeled NaF PET in newly diagnosed lung cancer, J Nucl Med, 42, 1800
Hsia, 2002, Comparing whole body 18F-2-deoxyglucose positron emission tomography and technetium-99m methylene diophosphate bone scan to detect bone metastases in patients with non-small cell lung cancer, Neoplasma, 49, 267
Schirrmeister, 2004, Omission of bone scanning according to staging guidelines leads to futile therapy in non-small cell lung cancer, Eur J Nucl Med Mol Imaging, 31, 964, 10.1007/s00259-004-1492-2
Cheran, 2004, Comparison of whole-body FDG-PET to bone scan for detection of bone metastases in patients with a new diagnosis of lung cancer, Lung Cancer, 44, 317, 10.1016/j.lungcan.2003.11.008
Gao, 2006, Diagnostic value of nuclide bone imaging for bone metastasis from lung cancer and clinic analysis, Chin J Lung Cancer, 9, 357
Song, 2009, Efficacy comparison between 18F-FDG PET/CT and bone scintigraphy in detecting bony metastases of non-small-cell lung cancer, Lung Cancer, 10.1016/j.lungcan.2008.12.004
Takenaka, 2009, Detection of bone metastases in non-small cell lung cancer patients: comparison of whole-body diffusion-weighted imaging (DWI), whole-body MR imaging without and with DWI, whole-body FDG-PET/CT, and bone scintigraphy, J Magn Reson Imaging, 30, 298, 10.1002/jmri.21858
Min, 2009, The role of whole-body FDG PET/CT, Tc 99m MDP bone scintigraphy, and serum alkaline phosphatase in detecting bone metastasis in patients with newly diagnosed lung cancer, J Korean Med Sci, 24, 275, 10.3346/jkms.2009.24.2.275
Costo, 2009, Usefulness of 99mTc-depreotide scintigraphy for the diagnosis of bone metastases in non-small cell lung cancer stage III–IV, Méd Nucl, 33, 201, 10.1016/j.mednuc.2008.10.015
Kruger, 2009, Detection of bone metastases in patients with lung cancer: 99mTc-MDP planar bone scintigraphy, 18F-fluoride PET or 18F-FDG PET/CT, Eur J Nucl Med Mol Imaging, 36, 1807, 10.1007/s00259-009-1181-2
Xu, 2009, Comparison of 18F-FDG PET-CT and 99mTc-MDP bone scintigraphy in detection of bone metastases, J Chin Clin Med Imaging, 20, 323
Liu, 2009, Bone metastasis in patients with non-small cell lung cancer: the diagnostic role of F-18 FDG PET/CT, Eur J Radiol
Lijmer, 1999, Empirical evidence of design-related bias in studies of diagnostic tests, JAMA, 282, 1061, 10.1001/jama.282.11.1061
Rutter, 2001, A hierarchical regression approach to meta-analysis of diagnostic test accuracy evaluations, Stat Med, 20, 2865, 10.1002/sim.942
Pham, 2001, Is there a “best” way to detect and minimize publication bias? An empirical evaluation, Eval Health Prof, 24, 109
Liang, 1993, Regression analysis for correlated data, Annu Rev Public Health, 14, 43, 10.1146/annurev.pu.14.050193.000355
Tryciecky, 1997, Oncologic imaging: interactions of nuclear medicine with CT and MRI using the bone scan as a model, Semin Nucl Med, 27, 142, 10.1016/S0001-2998(97)80044-X
Deeks, 2001, Systematic reviews of evaluations of diagnostic and screening tests, Br Med J, 323, 157, 10.1136/bmj.323.7305.157
Cook, 1998, Detection of bone metastases in breast cancer by 18FDG PET: differing metabolic activity in osteoblastic and osteolytic lesions, J Clin Oncol, 16, 3375, 10.1200/JCO.1998.16.10.3375
Hamaoka, 2004, Bone imaging in metastatic breast cancer, J Clin Oncol, 22, 2942, 10.1200/JCO.2004.08.181
Blake, 2001, Quantitative studies of bone with the use of 18F-fluoride and 99mTc-methylene diphosphonate, Semin Nucl Med, 31, 28, 10.1053/snuc.2001.18742
Cook, 2000, The role of positron emission tomography in the management of bone metastases, Cancer, 88, 2927, 10.1002/1097-0142(20000615)88:12+<2927::AID-CNCR8>3.0.CO;2-V
Loeffler, 1975, Limitations of bone scanning in clinical oncology, JAMA, 234, 1228, 10.1001/jama.234.12.1228
Sedonja, 1999, The benefit of SPECT when added to planar scintigraphy in patients with bone metastases in the spine, Clin Nucl Med, 24, 407, 10.1097/00003072-199906000-00006
Andrews, 2009, Diagnosis and staging of lung and pleural malignancy – an overview of tissue sampling techniques and the implications for pathological assessment, Clin Oncol, 21, 451